Cite
APA Citation
Mickevicius, T., Pink, A. E., Bhogal, M., O'Brart, D., & Robbie, S. J. (2023). dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management. Cornea, 42(4), 507–519. http://access.bl.uk/ark:/81055/vdc_100179858551.0x000048